Midline traction oral appliance for Snoring

Phase-Based Progress Estimates
Snoring+2 More
Midline traction oral appliance - Device
18 - 65
What conditions do you have?

Study Summary

This study is evaluating whether an oral appliance may help improve sleep quality for pregnant women who snore.

Eligible Conditions
  • Snoring
  • Sleep Fragmentation

Treatment Effectiveness

Study Objectives

1 Primary · 5 Secondary · Reporting Duration: At each of 3 time points over 5 weeks

Week 5
Fatigue Severity Scale (FSS)
Hamilton Depression Rating Scale (HDRS)
Insomnia Sleep Questionnaire (ISQ)
Pittsburgh Sleep Quality Index (PSQI)
Week 5
Number of snores per hour of sleep
Week 5
Ratio of stable to unstable sleep from CPC

Trial Safety

Trial Design

2 Treatment Groups

1 of 2
Midline traction oral appliance
1 of 2

Active Control

Experimental Treatment

20 Total Participants · 2 Treatment Groups

Primary Treatment: Midline traction oral appliance · No Placebo Group · N/A

Midline traction oral appliance
Experimental Group · 1 Intervention: Midline traction oral appliance · Intervention Types: Device
ControlNoIntervention Group · 1 Intervention: Control · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: at each of 3 time points over 5 weeks

Who is running the clinical trial?

Texas A&M UniversityLead Sponsor
122 Previous Clinical Trials
17,978 Total Patients Enrolled
1 Trials studying Snoring
70 Patients Enrolled for Snoring
Emet D Schneiderman, PhDPrincipal InvestigatorTexas A&M University College of Dentistry
Preetam J Schramm, PhDPrincipal InvestigatorTexas A&M University College of Dentistry

Eligibility Criteria

Age 18 - 65 · Female Participants · 6 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 16th, 2021

Last Reviewed: November 4th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.